23andMe particular committee once more rejects CEO Wojcicki’s take-private trade in

23andMe‘s particular committee of separate administrators on Monday unwelcome CEO Anne Wojcicki’s proposal to remove the distressed genetic checking out corporate deepest.

Wojcicki submitted an offer to the committee on Sunday, providing to obtain all the corporate’s remarkable stocks for 41 cents every, in step with a filing with the U.S. Securities and Alternate Fee.

The retain plunged 33% on Monday to similar at $1.47, ill greater than 99% from its top in 2021.

Wojcicki and Unutilized Mountain Capital submitted a previous bid in February to remove the corporate deepest for $2.53 in keeping with proportion. Days then, Unutilized Mountain advised Wojcicki it used to be not involved in taking part in a possible acquisition and would discontinue discussions, the submitting mentioned.

23andMe’s particular committee mentioned that Wojcicki’s proposal represented an 84% shorten from the prior trade in and aspiring to not advance ahead, in step with a release on Monday.

“The Special Committee has reviewed Ms. Wojcicki’s acquisition proposal in consultation with its financial and legal advisors, and has unanimously determined to reject the proposal,” the administrators mentioned.

23andMe didn’t straight away reply to CNBC’s request for remark.

Following a stormy 2024, 23andMe introduced plans in January to discover strategic alternatives, which might come with a sale of the corporate or its belongings, a restructuring or a industry aggregate. 

Wojcicki in the past submitted an offer to remove the corporate deepest for 40 cents in keeping with proportion in July, nevertheless it used to be rejected by means of the particular committee, partly since the contributors mentioned it lacked dedicated financing and didn’t lend a top rate to the ultimate value on the hour.

WATCH: The arise and fall of 23andMe